Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shelter PharmaBOM:543963 -2.26%66 Quick Ratio is 4.37 as of Mar. 2026, which is 154% above its 10-year median of 1.72. GuruFocus rates BOM:543963 with a GF Score™ of 66/100 and a GF Value™ of ₹57.02 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 998 Drug Manufacturers companies, Shelter Pharma ranks better than 86.97% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Shelter Pharma's quick ratio for the quarter that ended in Mar. 2026 was 4.37.
Shelter Pharma has a quick ratio of 4.37. It generally indicates good short-term financial strength.
The historical rank and industry rank for Shelter Pharma's Quick Ratio or its related term are showing as below:
BOM:543963'
s Quick Ratio Range Over the Past 10 Years
Min: 1.08 Med: 1.72 Max: 13.42
Current: 4.37
During the past 7 years, Shelter Pharma's highest Quick Ratio was 13.42. The lowest was 1.08. And the median was 1.72.
BOM:543963's Quick Ratio is ranked better than 86.97% of 998
companies
in the Drug Manufacturers industry
Industry Median: 1.43
vs BOM:543963: 4.37
Shelter Pharma (BOM:543963) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Shelter Pharma Quick Ratio Related Terms
Shelter Pharma Quick Ratio Historical Data
* Premium members only.
The historical data trend for Shelter Pharma's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Shelter Pharma's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shelter Pharma Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shelter Pharma's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Shelter Pharma's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Shelter Pharma's Quick Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shelter Pharma (BOM:543963) has a Quick Ratio of 4.37 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Shelter Pharma and its competitors. This is 154% above median its historical median of 1.72. Over the past decade, Shelter Pharma's Quick Ratio has ranged from 1.08 to 13.42. According to the industry distribution chart, Shelter Pharma ranks #130 out of 998 companies in the Drug Manufacturers industry, placing it in the top 13%.
Is Shelter Pharma's Quick Ratio too high?
Shelter Pharma's current Quick Ratio of 4.37 is 154% above median its 10-year median of 1.72. Over the past 10 years, this metric has ranged from a low of 1.08 to a high of 13.42. The Drug Manufacturers industry median Quick Ratio is 1.43. Shelter Pharma's value of 4.37 is 205.6% above this industry median. Based on the distribution chart, Shelter Pharma ranks #130 out of 998 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Shelter Pharma has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shelter Pharma's Quick Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Shelter Pharma ranks #130 out of 998 companies for Quick Ratio. This places Shelter Pharma in the top 13% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.43. Shelter Pharma's value of 4.37 is 205.6% above this benchmark. Historically, Shelter Pharma's own Quick Ratio has ranged from 1.08 to 13.42 over the past decade. While the company's 10-year median is 1.72 vs. the industry median of 1.43, Shelter Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.43, based on 998 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shelter Pharma's current Quick Ratio of 4.37 is 205.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Shelter Pharma and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shelter Pharma's current Quick Ratio is 4.37, which is 154% above median its own 10-year median of 1.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shelter Pharma stock overvalued right now?
Based on GuruFocus' analysis, Shelter Pharma (BOM:543963) is currently considered Possible Value Trap. The stock's GF Value™ is ₹57.02, compared to a current price of ₹26.00 — trading 54.4% below its estimated fair value. The current Quick Ratio is 4.37, which is 154% above median its 10-year median of 1.72 and 205.6% above the Drug Manufacturers industry median of 1.43. Shelter Pharma's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Shelter Pharma (BOM:543963), the current Quick Ratio is 4.37 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shelter Pharma (BOM:543963) Overvalued in 2026?
Based on GuruFocus' analysis, Shelter Pharma stock appears to be undervalued.
The current stock price of ₹26.00 is trading 54.4% below its estimated GF Value™ of ₹57.02.
GuruFocus considers Shelter Pharma to be Possible Value Trap.
Key valuation signals for BOM:543963:
Quick Ratio: 4.37 (154% above median its 10-year median of 1.72)
GF Value™: ₹57.02 vs. price of ₹26.00 (54.4% below fair value)
Industry Position: 205.6% above the Drug Manufacturers median (#130 of 998)
No single metric tells the full story. See the BOM:543963 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shelter Pharma Ltd focuses in manufacturing herbal products with a well-built presence in Human Pharma as well as the Veterinary space. It is present in majority of the non-critical segments of human and veterinary pharma through its well-spread portfolio. Its products include tablets, syrups, baby drops, barley water, oils, powders, ointments, etc.
66GF Score
Get the complete analysis for BOM:543963
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543963 has been successfully added to your 
